Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vadas

Showing results (21-30 of 635) with videos related to

Pageof 64
Sort By:
Cancer|June 1, 1973
Transitional cloacogenic carcinoma of the urethraL Lucman, G Vadas
The Journal of Allergy and Clinical Immunology|March 31, 2012
Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cellsPeter Vadas, Boris Perelman
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1986
Role of secretory phospholipases A2 in the pathobiology of diseaseP Vadas, W Pruzanski
Journal of the American Geriatrics Society|June 1, 1984
Benefits of access to on-site acute and critical care for the residential section of a multi-level geriatric centerM Gordon, P Vadas
Advances in Experimental Medicine and Biology|January 1, 1990
Soluble phospholipase A2 in human pathology: clinical-laboratory interfaceW Pruzanski, P Vadas
Critical Care Medicine|February 1, 1991
Plasma cortisol levels in patients with septic shockP Vadas, W Pruzanski
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 22, 2014
Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndromeAmanda Jagdis, Peter Vadas
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 17, 2007
Multivalency - a way to enhance binding avidities and bioactivity - preliminary applications to EPOOscar Vadas, Keith Rose
The Journal of Rheumatology|November 1, 1988
Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritisW Pruzanski, P Vadas
Annals of the Rheumatic Diseases|November 1, 1989
Phospholipase A2 and inflammationW Pruzanski, P Vadas
Pageof 64

Showing results (21-30 of 635) with videos related to

Sort By:
Pageof 64
Cancer|June 1, 1973
Transitional cloacogenic carcinoma of the urethraL Lucman, G Vadas
The Journal of Allergy and Clinical Immunology|March 31, 2012
Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cellsPeter Vadas, Boris Perelman
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1986
Role of secretory phospholipases A2 in the pathobiology of diseaseP Vadas, W Pruzanski
Journal of the American Geriatrics Society|June 1, 1984
Benefits of access to on-site acute and critical care for the residential section of a multi-level geriatric centerM Gordon, P Vadas
Advances in Experimental Medicine and Biology|January 1, 1990
Soluble phospholipase A2 in human pathology: clinical-laboratory interfaceW Pruzanski, P Vadas
Critical Care Medicine|February 1, 1991
Plasma cortisol levels in patients with septic shockP Vadas, W Pruzanski
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 22, 2014
Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndromeAmanda Jagdis, Peter Vadas
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 17, 2007
Multivalency - a way to enhance binding avidities and bioactivity - preliminary applications to EPOOscar Vadas, Keith Rose
The Journal of Rheumatology|November 1, 1988
Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritisW Pruzanski, P Vadas
Annals of the Rheumatic Diseases|November 1, 1989
Phospholipase A2 and inflammationW Pruzanski, P Vadas
Pageof 64